Search

Now showing items 1-10 of 62

Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical staging

Gultekin, Melis; Guler, Ozan Cem; Sari, Sezin Yuce; Yildirim, Berna Akkus; Onal, Cem; Celik, Husnu; Yuce, Kunter; Ayhan, Ali; Arik, Zafer; Kose, Fatih; Altundag, Ozden; Mustafayev, Teuta Zoto; Atalar, Banu; Bolukbasi, Yasemin; Yildiz, Ferah (2020)

In this study, 683 patients with endometrial cancer (EC) after comprehensive surgical staging were classified into four risk groups as low (LR), intermediate (IR), high-intermediate (HIR) and high-risk (HR), according to ...

The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.

Cem, Onal; Sedef, Ali Murat; Kose, Fatih; Oymak, Ezgi; Guler, Ozan Cem; Sumbul, Ahmet Taner; Aksoy, Sercan; Yildirim, Berna Akkus; Besen, Ali Ayberk; Mullaoglu, Sadik; Mertsoylu, Huseyin; Ozyigit, Gokhan (2019)

The outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.

Yildirim, Berna; Cem, Onal; Kose, Fatih; Oymak, Ezgi; Sedef, Ali Murat; Besen, Ali Ayberk; Aksoy, Sercan; Guler, Ozan Cem; Sumbul, Ahmet Taner; Mertsoylu, Huseyin; Ozyigit, Gokhan (2019)

Is there a correlation between Gleason score and maximum standardized uptake value in locally advanced prostate cancer patients?

Cem, Onal; Torun, Nese; Guler, Ozan Cem; Reyhan, Mehmet; Yildirim, Berna Akkus; Yapar, Ali Fuat (2019)

Graves' Ophthalmopathy Treated with Protracted Hypofractionated Low-Dose Adaptive Radiotherapy: Case Report and Review of The Literature

Guler, Ozan Cem; Onal, Cem (2016)

Graves' ophthalmopathy (GO) is the most common extra-thyroidal manifestation of Graves' disease. The treatment options for GO are high-dose glucocorticoids, selenium, rituximab, cyclosporine, orbital radiotherapy (RT), and ...

Metachronous Prostate Metastasis of Renal Cell Carcinoma: Case Report and Review of the Literature

Guler, Ozan Cem; Bal, Nebil; Onal, Cem (2016)

Secondary tumors of the prostate are very rare, and only a few reports of prostate metastasis originating from renal cell carcinoma (RCC) have been published. The reported 5-year survival rate has been approximately 35% ...

Retrospective Comparison of Standard and Escalated Doses of Radiotherapy in Newly Diagnosed Glioblastoma Patients Treated with Concurrent and Adjuvant Temozolomide

Guler, Ozan Cem; Yildirim, Berna Akkus; Onal, Cem; Topkan, Erkan (2019)

BACKGROUND: To compare the efficacies of standard dose-(SDRT) and escalated dose radiotherapy (EDRT) in newly diagnosed glioblastoma (GBM) with concurrent and adjuvant temozolomide (TMZ). MATERIALS AND METHODS: Outcomes ...

Prostate-specific membrane antigen PET response associates with radiographic progression-free survival following stereotactic ablative radiation therapy in oligometastatic castration-sensitive prostate cancer.

Sutera, Philip; Deek, Matthew; Guler, Ozan Cem; Hurmuz, Pervin; Reyhan, Mehmet; Rowe, Steven P.; Hrinivich, William; Ren, Lei; Kiess, Ana Ponce; Song, Daniel Y.; Oymak, Ezgi; Pienta, Kenneth J.; Pomper, Martin; Feng, Felix Y.; Ozyigit, Gokhan; Tran, Phuoc T.; Phillips, Ryan; Onal, Huseyin Cem (2022)

Effect of Adjuvant Extended Temozolamide Treatment in Survival of Patients with Glioblastoma Multiforme

Yildirim, Berna Akkus; Sumbul, Ahmet Taner; Topkan, Erkan; Ozdemir, Yurday; Besen, Ali Ayberk; Guler, Ozan Cem; Sedef, Ali Murat; Onal, Cem (2018)

Purpose: The aim of this retrospective cohort study was to evaluate the prognostic effect extended temozolamide on survival outcomes of glioblastoma multiforme patients who were underwent surgery/biopsy followed treated ...

The Utility of Pretreatment and Posttreatment Lymphopenia in Cervical Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy

Onal, Cem; Yildirim, Berna Akkus; Guler, Ozan Cem; Mertsoylu, Huseyin (2018)

Objective: The aim of this study was to investigate the prognostic significance of pretreatment and posttreatment lymphopenia in locally advanced squamous cell carcinoma (SCC) cervical cancer patients treated with definitive ...

1
2
3
4
. . .
7